—

Admetsys Corporation

Phase 2 Estimated

Undisclosed program

Hyperglycemia

Countdown

146days

Phase 2 readout · ~ Nov 30, 2026 estimated

What's at stake Phase 2 trial results for Undisclosed program in Hyperglycemia are due ~ Nov 30, 2026. A clean hit validates the program; a miss can gap the stock down hard.

Primary source · ClinicalTrials.gov verified 15h ago

“CT.gov NCT01291719: Phase 2 trial, sponsor Admetsys Corporation. Primary completion date 2026-11 (estimated).”

Add to calendar Post on X Reddit

Provenance